Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cell Death Discovery|August 17, 2021
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancerWeiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M A Pillai, et al.
Cancer Letters|September 15, 2023
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancerPrabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, et al.
Neuro-Oncology|January 18, 2023
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastomaSalvador Alejo, Bridgitte E Palacios, Prabhakar Pitta Venkata, et al.
NPJ Precision Oncology|May 24, 2024
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosisBehnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Cancer Research|August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast CancerKristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.
Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Oncogene|February 6, 2026
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancerSuryavathi Viswanadhapalli, Tae-Kyung Lee, Scott Elmore, et al.
Pageof 6